About Us

Who We Are

We provide biomanufacturing strategy and execution to startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, government agencies, financial institutions, CROs/CMOs, not-for-profit organizations and medical device companies. Our services include turnkey capital projects, tech transfers and facility builds; owner's representation; project and program management; validation; quality, regulatory and compliance; engineering and automation; serialization / track and trace; reliability, compliance and asset management; and more. We are committed to advancing manufacturing to achieve operational excellence and accelerate speed to market for next-generation medicines.

FOOTPRINT, TEAM & CULTURE

Our Team

Our strategy is to hire, train and develop full-time employees, not temporary or 1099 contractors, that become the backbone of our company. We boast a less than 7% employee turnover rate and over 4.5 Glassdoor rating.

Our Culture

We foster a collaborative environment that promotes an engaging culture among our team members and clients. As a result, our team is able to overcome obstacles and provide exceptional project delivery. Our Glassdoor reviews boast of a “team-oriented nurturing environment” that “stresses a culture that is inclusive” and “values people and maintains a patient-focused mentality.”

Patient Focused

We named our firm “Project Farma” to remind our team why they come to work every day: for the patients. We believe that having a focus on philanthropy and connecting our team to the patients allows for a culture focused on providing solutions, meeting deadlines & getting results.

PF CARES

We are driven by our C.A.R.E.S. philosophy - Culture Focused, Agile Integration, Results Driven, Execution Excellence, Strategic Partnerships. It is our foundation for providing exceptional service and results that are required by our trusted partners. Our CARES philosophy focuses on the value of our partnerships and our team members. It is the foundation for our and our partners' success.

Diversity

We value the diversity of our team members and their unique perspectives and experiences. Diversity is not only age, race, sex, sexual orientation, military status, disabilities, and ethnicity but also geographic locations, clients and their respective markets, roles and responsibilities, job functions, and educational background. By valuing these differences, we evolve and successfully demonstrate our commitment to our CARES philosophy and treating everyone with fairness and respect.

Results & Efficiency

As a result of our culture and philosophy, Project Farma provides a motivated project delivery team that has a track record of creating 5-15% efficiency savings, limiting scope creep and delivering projects on time and on budget.


Philanthropy

Philanthropy is Built
into our Foundation

As a patient-focused delivery team, we are committed to connecting our team members to patients and their families. Connecting our team to the patients has fostered a culture within our organization that is focused on providing solutions, meeting deadlines and getting results.

Learn More
PF Team

Project Farma Leadership Team

Anshul Mangal

Anshul Mangal

CEO & General Counsel

anshulmangal

@projectfarma.com

773.531.2120

Anshul Mangal

CEO & General Counsel

Anshul is a biotech entrepreneur, experienced CEO and attorney. He is the founder, CEO and general counsel of Project Farma (“PF”).

Anshul founded and grew PF into a leading worldwide biologics and advanced therapy engineering consulting firm. In addition, Anshul has served as general counsel and managed all corporate legal transactions. Under Anshul’s leadership, PF pioneered the industrialization of advanced therapies including two FDA-approved cell and gene therapies and created PF’s Advanced Therapy Manufacturing Playbook. This playbook helped develop the largest cell and gene therapy manufacturing footprint in the world. In addition to PF, Anshul is an investor and founder of several biotechs, real estate and hospitality companies. Prior to PF, Anshul was a patent litigator at Jones Day and a consultant at Morgan Stanley & Discover Financial Services.


Tony Khoury

Tony Khoury

Vice President

tonykhoury

@projectfarma.com

312.771.4947

Tony Khoury

Vice President

Tony Khoury is an experienced industry leader in life sciences, specifically, biologics and advanced therapies. As a member of the Project Farma leadership team, Tony has spearheaded the firm’s growth in the biologics and most recently next generation medicines. Tony has extensive experience with small and large molecules including biologics, biosimilars, and cell and gene therapies. He has worked with small and large life science organizations including startups, academic centers, financial institutions and CMOs/CROs. He has led global programs greater than $350+ million in the following disciplines: project management, turnkey facility builds, automation, validation, engineering and serialization track and trace. Recently, Tony has pioneered the industrialization of advanced therapies including two FDA-approved cell and gene therapies. Tony has led the creation of Project Farma’s Advanced Therapy Manufacturing Playbook which has helped develop the largest cell and gene therapy manufacturing footprint in the world.


John Khoury

John Khoury

Vice President

johnkhoury

@projectfarma.com

847.754.7487

John Khoury

Vice President

John Khoury is a 20+ year veteran and leader in the biotech / pharmaceutical industry. As a member of the Project Farma Leadership Committee, John has spearheaded Project Farma’s growth in the gene and cell therapy space. He has led and provided strategy on key partner initiatives including make vs. buy analysis, site and vendor selection, tech transfer execution strategies, and facility start-ups. 

In addition to his experience in advanced therapies, John has extensive experience with small and large molecules including biologics and biosimilars. Over the past four years, he has led facility builds totaling over $500MM. During this time, he has worked with small and large biotech and pharmaceutical companies including gene and cell therapy startups and CMOs/CROs.


Scott Deckrow

Scott Deckrow

Business Operations

scottdeckrow

@projectfarma.com

813.394.4924

Scott Deckrow

Business Operations


Cory Proctor

Cory Proctor

Cory Proctor


Sarah Stoll

Sarah Stoll

Sarah Stoll


Jim Watson

Jim Watson

Jim Watson


Julia Taicsich

Julia Taicsich

Julia Taicsich


Nathan Traughber

Nathan Traughber

Nathan Traughber


Joseph Neroni

Joseph Neroni

Joseph Neroni


Lesley Davis

Lesley Davis

Lesley Davis


Landon DeCosta

Landon DeCosta

Landon DeCosta


Phil Massey

Phil Massey

Phil Massey


Ally Viggiani

Ally Viggiani

Ally Viggiani


Jessica Cook

Jessica Cook

Jessica Cook


Connor Rudny

Connor Rudny

Connor Rudny


Emily Crumpton

Emily Crumpton

Emily Crumpton